S 5059 · 119th Congress

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

Introduced Jul 21, 2026Last action Jul 21, 2026Congress.gov →

Latest action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsor

2 D · 1 R